A number of non-tuberculous mycobacterium species are opportunistic pathogens and ubiquitously form biofilms. These infections are often recalcitrant to treatment and require therapy with multiple drugs for long duration. The biofilm resident bacteria also display phenotypic drug tolerance and thus it has been hypothesized that the drug unresponsiveness in vivo could be due to formation of biofilms inside the host. We have discussed the biofilms of several pathogenic non-tuberculous mycobacterium (NTM) species in context to the in vivo pathologies. Besides pathogenic NTMs, Mycobacterium smegmatis is often used as a model organism for understanding mycobacterial physiology and has been studied extensively for understanding the mycobacterial ...
This is the publisher’s final pdf. The published article is copyrighted by the author(s) and publish...
Biofilms represent universal strategy for bacterial survival. Living in form of biofilms, bacteria a...
Successful treatment of human tuberculosis requires 6-9 months' therapy with multiple antibiotics. I...
Mycobacteria naturally grow as corded biofilms in liquid media without detergent. Such detergent-fre...
Graduation date: 2016Respiratory infections caused by nontuberculous mycobacteria (NTM), especially ...
A non-tuberculous mycobacterium, Mycobacterium abscessus is an emerging opportunistic pathogen assoc...
Mycobacterium tuberculosis (Mtb) causes tuberculosis (TB). The treatment of TB requires administrati...
Mycobacterium tuberculosis, the etiologic agent of human tuberculosis, has an extraordinary ability ...
Mycobacterium tuberculosis, the etiologic agent of human tuberculosis, has an extraordinary ability ...
The complex cell wall and biofilm matrix (ECM) act as key barriers to antibiotics in mycobacteria. H...
The complex cell wall and biofilm matrix (ECM) act as key barriers to antibiotics in mycobacteria. H...
AbstractNontuberculous mycobacteria (NTM) are emergent pathogens whose importance in human health ha...
Tuberculosis is the leading cause of death due to a single infectious agent, and over one-third of t...
Successful treatment of human tuberculosis requires 6-9 months' therapy with multiple antibiotics. I...
The antibiotic-tolerant biofilms present in tuberculous granulomas add an additional layer of comple...
This is the publisher’s final pdf. The published article is copyrighted by the author(s) and publish...
Biofilms represent universal strategy for bacterial survival. Living in form of biofilms, bacteria a...
Successful treatment of human tuberculosis requires 6-9 months' therapy with multiple antibiotics. I...
Mycobacteria naturally grow as corded biofilms in liquid media without detergent. Such detergent-fre...
Graduation date: 2016Respiratory infections caused by nontuberculous mycobacteria (NTM), especially ...
A non-tuberculous mycobacterium, Mycobacterium abscessus is an emerging opportunistic pathogen assoc...
Mycobacterium tuberculosis (Mtb) causes tuberculosis (TB). The treatment of TB requires administrati...
Mycobacterium tuberculosis, the etiologic agent of human tuberculosis, has an extraordinary ability ...
Mycobacterium tuberculosis, the etiologic agent of human tuberculosis, has an extraordinary ability ...
The complex cell wall and biofilm matrix (ECM) act as key barriers to antibiotics in mycobacteria. H...
The complex cell wall and biofilm matrix (ECM) act as key barriers to antibiotics in mycobacteria. H...
AbstractNontuberculous mycobacteria (NTM) are emergent pathogens whose importance in human health ha...
Tuberculosis is the leading cause of death due to a single infectious agent, and over one-third of t...
Successful treatment of human tuberculosis requires 6-9 months' therapy with multiple antibiotics. I...
The antibiotic-tolerant biofilms present in tuberculous granulomas add an additional layer of comple...
This is the publisher’s final pdf. The published article is copyrighted by the author(s) and publish...
Biofilms represent universal strategy for bacterial survival. Living in form of biofilms, bacteria a...
Successful treatment of human tuberculosis requires 6-9 months' therapy with multiple antibiotics. I...